These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 12921254)
1. Capecitabine-induced pancreatitis. Jones KL; Valero V Pharmacotherapy; 2003 Aug; 23(8):1076-8. PubMed ID: 12921254 [TBL] [Abstract][Full Text] [Related]
2. Safety profile and activity of lower capecitabine dose in patients with metastatic breast cancer. Rossi D; Alessandroni P; Catalano V; Giordani P; Fedeli SL; Fedeli A; Baldelli AM; Casadei V; Ceccolini M; Catalano G Clin Breast Cancer; 2007 Dec; 7(11):857-60. PubMed ID: 18269775 [TBL] [Abstract][Full Text] [Related]
3. Capecitabine-induced severe hypertriglyceridemia: report of two cases. Kurt M; Babaoglu MO; Yasar U; Shorbagi A; Guler N Ann Pharmacother; 2006 Feb; 40(2):328-31. PubMed ID: 16391007 [TBL] [Abstract][Full Text] [Related]
4. Lower dose capecitabine has a more favorable therapeutic index in metastatic breast cancer: retrospective analysis of patients treated at M. D. Anderson Cancer Center and a review of capecitabine toxicity in the literature. Hennessy BT; Gauthier AM; Michaud LB; Hortobagyi G; Valero V Ann Oncol; 2005 Aug; 16(8):1289-96. PubMed ID: 15890665 [TBL] [Abstract][Full Text] [Related]
5. [A woman with palmar and plantar hyperpigmentation]. van Tienhoven G; Wilmink JW Ned Tijdschr Geneeskd; 2011; 155(45):A4100. PubMed ID: 22085578 [TBL] [Abstract][Full Text] [Related]
6. Palmar-plantar erythrodysesthesia due to docetaxel-capecitabine therapy is treated with vitamin E without dose reduction. Kara IO; Sahin B; Erkisi M Breast; 2006 Jun; 15(3):414-24. PubMed ID: 16188440 [TBL] [Abstract][Full Text] [Related]
7. Hypertriglyceridaemia-induced pancreatitis: a contributory role of capecitabine? Chan HY; Ng CM; Tiu SC; Chan AO; Shek CC Hong Kong Med J; 2012 Dec; 18(6):526-9. PubMed ID: 23223655 [TBL] [Abstract][Full Text] [Related]
8. [Breast cancer and the hand-foot syndrome]. Llambrich C; Falcou MC; De Rycke Y; Cottu P; Carrié S; Medjbari M Soins; 2012 Jun; (766):25-8. PubMed ID: 22870762 [TBL] [Abstract][Full Text] [Related]
9. Capecitabine as salvage therapy for a breast cancer patient with extensive liver metastases and associated impairment of liver function. Schüll B; Scheithauer W; Kornek GV Onkologie; 2003 Dec; 26(6):578-80. PubMed ID: 14709934 [TBL] [Abstract][Full Text] [Related]
10. Phase II trial of capecitabine and weekly paclitaxel in patients with metastatic breast cancer previously treated with every-3-week taxane therapy. Blum JL; Dees EC; Vukelja SJ; Amare M; Gill DP; McMahon RT; Ilegbodu D; Asmar L; O'Shaughnessy JA Clin Breast Cancer; 2007 Feb; 7(6):465-70. PubMed ID: 17386123 [TBL] [Abstract][Full Text] [Related]
11. Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer. Gajria D; Gonzalez J; Feigin K; Patil S; Chen C; Theodoulou M; Drullinsky P; D'Andrea G; Lake D; Norton L; Hudis CA; Traina TA Breast Cancer Res Treat; 2012 Jan; 131(1):111-6. PubMed ID: 21898114 [TBL] [Abstract][Full Text] [Related]
12. Response to low-dose oral capecitabine monotherapy in an elderly frail patient with metastatic breast carcinoma and impaired renal function: documentation by fluorodeoxyglucose positron emission tomography. Basu S; Baghel NS Jpn J Radiol; 2011 May; 29(4):291-2. PubMed ID: 21607846 [No Abstract] [Full Text] [Related]
13. Capecitabine and PPE syndrome: a case report. LoRusso PM Breast J; 2003; 9(1):64-5. PubMed ID: 12558679 [No Abstract] [Full Text] [Related]
14. Capecitabine-induced hypertriglyceridemia and hyperglycemia: two cases. Duman BB; Paydas S; Tetiker T; Gunaldı M; Afsar CU; Erçolak V; Haksöyler V; Dilli MŞ Pharmacology; 2012; 90(3-4):212-5. PubMed ID: 23038659 [TBL] [Abstract][Full Text] [Related]
15. Breast cancer, DPYD mutations and capecitabine-related ileitis: description of two cases and a review of the literature. Mokrim M; Aftimos PG; Errihani H; Piccart-Gebhart M BMJ Case Rep; 2014 Apr; 2014():. PubMed ID: 24748142 [TBL] [Abstract][Full Text] [Related]
16. Capecitabine: a review. Walko CM; Lindley C Clin Ther; 2005 Jan; 27(1):23-44. PubMed ID: 15763604 [TBL] [Abstract][Full Text] [Related]
17. [Unilateral acral necrosis as a minor form of hand-foot syndrome. Patient with unilateral acral necrosis secondary to capecitabine therapy for metastatic breast cancer]. Sauter C; Saborowski A; Ockenfels HM Hautarzt; 2007 Jul; 58(7):619-22. PubMed ID: 17066280 [TBL] [Abstract][Full Text] [Related]
19. Clinical features of oral chemotherapy: results of a longitudinal prospective study of breast and colorectal cancer patients receiving capecitabine in the UK. Brearley SG; Craven O; Saunders M; Swindell R; Molassiotis A Eur J Cancer Care (Engl); 2010 Jul; 19(4):425-33. PubMed ID: 19708942 [TBL] [Abstract][Full Text] [Related]
20. Capecitabine-induced diffuse palmoplantar keratoderma: is it a sequential event of hand-foot syndrome? Do JE; Kim YC Clin Exp Dermatol; 2007 Sep; 32(5):519-21. PubMed ID: 17509060 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]